Pulmonary Hypertension Trial, Recruiting NCT05958901 Sponsor: The First Affiliated Hospital of Guangzhou Medical University Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT05958901
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose average blood pressure in the lung arteries is higher than 25mmHg while at rest, or higher than 30mmHg during exercise.
  • People who are willing and able to follow the study requirements, including attending study visits over a 5-year period, and who have signed a consent form before taking part.

Who may not be able to join:

  • People who have had a sudden worsening of their condition in the past 3 months.
  • People who have another lung disease that has caused major damage to lung tissue, such as severe bronchiectasis or tuberculosis.
  • People who have a serious uncontrolled illness, or who have had chest or abdominal surgery in the last 3 months.
  • People who have had eye surgery in the last 3 months.
  • People who have had a detached retina or a heart attack in the last 3 months.
  • People who have been admitted to hospital for any heart-related condition in the last month.
  • People whose heart rate is over 120 beats per minute.
  • People who are currently receiving antibiotic treatment for tuberculosis.
  • People who are pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Registry
ClinicalTrials.gov
Start date
12 July 2023
Est. completion
30 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

mean pulmonary arterial pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov